Target intelligence / Profile preview

Heat shock protein 90kDa alpha (cytosolic), class A member 6, pseudogene (HSP90AA6P)

Target
HSP90AA6P
Molecular classification
Other (Pseudogene), Not a receptor, enzyme, transporter, ion channel, transcription factor, etc., Homolog of chaperone protein family (HSP90)[2][3]
01

Overview

HSP90AA6P is a human pseudogene that shares homology with the active heat shock protein 90kDa alpha (Hsp90α), a stress-inducible molecular chaperone involved in protein folding, stabilization, and degradation. Unlike its ancestral gene (HSP90AA1), HSP90AA6P does not encode a functional chaperone protein and thus does not participate directly in cellular stress response or protein homeostasis. Pseudogenes may have a coding-independent role at the RNA level, such as acting as a microRNA decoy, thereby modulating the expression of the parental gene and potentially influencing disease processes indirectly[6]. However, there is no experimental or clinical evidence indicating therapeutic target status, drug interaction, or established disease relevance for HSP90AA6P itself.

Other names
HSP90Afheat shock protein 90Afheat shock protein 90kDa alpha (cytosolic), class A member 1 pseudogeneheat shock protein 90kDa alpha (cytosolic), class A member 6, pseudogeneheat shock protein 90kDa alpha family class A member 6, pseudogene[2]
02

Mechanism of action

None for HSP90AA6P (noncoding pseudogene). For parental HSP90AA1 protein: inhibition of ATPase activity disrupts chaperone function, leading to cell death in tumor cells[3].

03

Biological functions

None confirmed for protein product; pseudogenes do not encode proteins.Potential regulatory function through RNA-based mechanisms, such as microRNA decoy or modulation of parental gene expression, as seen with other pseudogenes[6].No chaperone function (no active protein product)[6].
04

Disease associations

None confirmed specifically for HSP90AA6P.The parental HSP90AA1 (Hsp90α) has documented roles in cancer, immune response, and other disease states, but pseudogenes like HSP90AA6P may only indirectly influence disease through RNA regulation[5][6].
05

Safety considerations

None reported for HSP90AA6P.Therapeutic challenges and safety issues for Hsp90-targeting drugs refer to the protein, not pseudogene[3][5].
06

Interacting drugs

None known for HSP90AA6P.

1 more in the full profile.

07

Biomarkers

None specific for HSP90AA6P.The parental HSP90AA1/Hsp90α is a biomarker in several cancers (prognostic indicator), but not the pseudogene[5].

Beyond the preview

Go deeper on Heat shock protein 90kDa alpha (cytosolic), class A member 6, pseudogene (HSP90AA6P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock protein 90kDa alpha (cytosolic), class A member 6, pseudogene (HSP90AA6P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call